Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/2002
09/12/2002US20020127197 Methods for treating urinary incontinence in mammals
09/12/2002US20020127182 Paramagnetic metal ion-based macrocylic magnetization transfer contrast agents and method of use
09/12/2002US20020127181 Antagonist diamidediphenolate compounds attached to a metal chelate and linking group; use as contrast agents for X-ray imaging and magnetic resonance imaging
09/12/2002DE10111516A1 Verwendung von Sydnoniminen zur spezifischen Diagnose erektiler Dysfunktionen Use of sydnonimines for specific diagnosis of erectile dysfunction
09/12/2002CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
09/11/2002EP1238666A2 Use of xanthenone-4-acetic acid in the manufacture of a medicament in the treatment of hyperproliferative disorders
09/11/2002EP1237583A1 Near infrared fluorescent contrast agent and fluorescence imaging
09/11/2002EP1237578A2 Micro-cluster liquids and methods of making and using them
09/11/2002EP0809519B1 Compositions comprising tricodobenzene polymers for imaging the gastrointestinal tract
09/10/2002US6448442 Contrast media
09/10/2002US6448253 Adenosine A3 receptor modulators
09/10/2002US6447749 Perfluoro-alkyl containing dye molecules and galencial formulations
09/06/2002WO2002068930A2 Methods and reagents to acquire mri signals and images
09/06/2002WO2002068000A2 Polymeric imagable brachytherapy seed
09/06/2002WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues
09/06/2002WO2002067908A1 Novel dendritic polymers and their biomedical uses
09/06/2002WO2002067850A2 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging
09/06/2002WO2002067761A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
09/06/2002WO2002067668A1 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof
09/06/2002WO2002055089A3 Immunoassay technique using multispecific molecules
09/06/2002WO2002032421A8 Indole compounds as minimally physiologial function monitioring agents
09/06/2002WO2002032292A3 Methods for development and use of diagnostic and therapeutic agents
09/06/2002WO2001091805A3 Compounds for targeting endothelial cells
09/06/2002WO2001066156A3 Use of radiopharmaceuticals and intraoperative radiation probe
09/06/2002WO2001018011A9 Calcium complex of phosphorus containing ethylenediamine derivatives
09/06/2002WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
09/06/2002CA2617004A1 Noninvasive measurements of chemical substances
09/06/2002CA2439298A1 Methods and reagents to acquire mri signals and images
09/06/2002CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues
09/06/2002CA2438193A1 Novel dendritic polymers and their biomedical uses
09/06/2002CA2438174A1 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
09/05/2002US20020124272 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm
09/05/2002US20020123532 E.g., bis(3,5-dibromo-2,4,6-trihydroxyphenyl)squaraine and bis(3,5- diiodo-2,4,6-trihydroxyphenyl)squaraine; anticarcinogenic and-tumor agents; fluorescent detector of tumors; sterilization of water; stability; nontoxic
09/05/2002US20020123478 Synthetic transfection vectors
09/05/2002US20020123043 Detecting ligand for preferential receptor; provide a substrate bound receptor, expose to sample, detect bound ligand by spectrum analysis
09/05/2002US20020122236 Methods and apparatus for optical imaging
09/04/2002EP1235515A1 Fullerene contrast agent for magnetic resonance imaging and spectroscopy
09/04/2002EP1235482A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions
09/04/2002EP0999849B1 Use of lbp in the treatment of septicaemia
09/04/2002EP0748229B1 Polychelants
09/04/2002EP0711355B1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
09/04/2002CN1367792A Somatostatin agonists
09/04/2002CN1367688A Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to graft
09/04/2002CN1090031C Novel use of ACE-inhibitor for treatment of dyspeptic symptoms
09/04/2002CN1090030C Complex cow's milk gamma globulin and making method thereof
09/03/2002US6444872 Fungicide therapy calibration
09/03/2002US6444660 Dexamethasone covalently bonded to a lipid moiety via a linking group
09/03/2002US6444638 Administering protein kinase c inhibitor and antitumor agent
09/03/2002US6444446 Calcium binding proteolipid compositions and methods
09/03/2002US6444193 Process for preparation of gas containing vesicles
09/03/2002US6444192 Diagnostic imaging of lymph structures
09/03/2002US6443898 Therapeutic delivery systems
09/03/2002CA2160764C Fish pancreatic disease virus
09/03/2002CA2096841C Drug delivery porphyrin compositions and methods
09/03/2002CA2001815C Products and methods for controlling the suppression of the neoplastic phenotype
08/2002
08/29/2002WO2002066264A2 Tatoo method and system for medical and surgical applications
08/29/2002WO2002066074A2 Method for assessing food allergenicity
08/29/2002WO2002038190A3 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
08/29/2002WO2002024235A3 Prochelators of radiometal labeled molecules
08/29/2002WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo
08/29/2002WO2001096547A3 Human kinases
08/29/2002WO2001089455A3 System and method for assessing the performance of a pharmaceutical agent delivery system
08/29/2002WO2001082975A3 Membrane-permeant peptide complexes for medical imaging
08/29/2002WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
08/29/2002WO2001020019A9 Implantable glucose sensor
08/29/2002WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery
08/29/2002US20020120123 Human vascular endothelial growth factor 2
08/29/2002US20020119926 Inhibitors of IAPP fibril formation and uses thereof
08/29/2002US20020119582 Signal enhancement of bispecific antibody-polymer probe for immunoassay use
08/29/2002US20020119502 Screening drugs for use in the treatment of mammary gland cancer; obtain animal, inject or orally administer anticarcinogeneic agent, monitor animal for development of cancer
08/29/2002US20020119488 In vitro method for treating cancer; obtain stem cells, incubate with carriers specific for tumor cells, separate conjugate, purge blood cells and/or bone marrow
08/29/2002US20020119471 Diagnosing allergic contact dermatitis in humans; obtain cells, isolate nucleotide sequences coding interleukins, monitor expression of interleukin polypeptide
08/29/2002US20020119102 For ultrasound contrast enhancement
08/29/2002US20020119101 Suitable for use in medical diagnosis
08/29/2002US20020119100 Capable of simply and accurately detecting initial dental caries without impairing the aesthetics
08/29/2002US20020119097 Ephrin-B2 is an early marker of angiogenesis; administering a molecule capable of detecting ephrin-B2 nucleic acid or polypeptide coupled to an imaging agent, detecting the accumulated molecule to image the tumor vasculature
08/28/2002EP0868202B1 Cascade polymer complexes, process for producing the same and pharmaceuticals containing the same
08/28/2002EP0741741B1 Modified oligonucleotides
08/27/2002US6441235 Preparation of 5-amino-isophthalamides
08/27/2002US6441053 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same
08/27/2002US6440956 Bicyclic polyaminoacid metal complexes, their process of preparation and their application in medical imaging
08/27/2002US6440950 Selective and non-invasive visualization or treatment of vasculature
08/27/2002US6440948 Thiophene A2A receptor agonists
08/27/2002US6440742 Recombinant AAV vector-based transduction system and use of same
08/27/2002US6440665 Modified bioluminescent proteins and their use
08/27/2002US6440389 Monitoring in vivo glomerular filtration, renal blood flow, or hepatic function; lanthanide ion chelated with a tetra-carboxytetraazamacrocycle; nonradioactive; can be used in surgery, infants and pregnant or postpartum women
08/27/2002US6440388 With a dye that binds to chitin and emits fluorescence upon exposure to light; detecting insects such as lice, ticks or fungi such as epidermophyton, microsporum or trichophyton species
08/27/2002US6440058 Radioactive seeds and method for using same
08/27/2002US6439236 Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles
08/22/2002WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
08/22/2002WO2002064084A2 In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease
08/22/2002WO2002064062A2 Vertebroplasty injection device and bone cement therefor
08/22/2002WO2002040061A3 Immunocompetent animals including xenogeneic implants of mesenchymal stem cells
08/22/2002WO2002013875A3 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
08/22/2002WO2002002773A3 Dual specificity antibodies and methods of making and using
08/22/2002WO2001089586A3 Tc and re carbonyl complexes for pertechnetate and perrhenate
08/22/2002WO2001085013A3 Infrared thermography and methods of use
08/22/2002US20020115112 Neutrokine-alpha and Neutrokine-alpha splice variant
08/22/2002US20020115086 Diagnosing allergic dermatitis in humans; obtain cells, extract nucleotide sequence, incubate with probes, measure concentration of preferential interleukin, ampified concentrations of interleukins in skin indicates allergic
08/22/2002US20020114815 Methods and kits for indentifying ductal orifices in a nipple